RECRUITING

Light Therapy Intervention in Individuals With Parkinson's Disease

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study looks to investigate the effects that light therapy delivered to the frontal cortex could have on Parkinson's disease related symptoms ( both cognitive and motor). The therapy is a non invasive technique that deliverers low level wavelength light to the front part of the head for 12 minutes. for this study the therapy will be done 3 times a week for 6 weeks. To measure the potential effects on the therapy in Parkinson symptoms, we will do a set of cognitive and motor test before and after the intervention to measure any changes as well as control for any potential markers such as age, sex, disease level, medication and exercise.

Official Title

Light Therapy Intervention in Individuals With Parkinson's Disease

Quick Facts

Study Start:2025-04-04
Study Completion:2026-07-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06916260

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of Parkinson disease
  1. 1. Participants who are unable to comply with study visit/testing requirements (e.g.
  2. 2. Participants who are unable to provide consent.
  3. 3. Participants with a Deep Brain Stimulation (DBS) device.
  4. 4. Participants who have a history of a psychiatric disorder
  5. 5. Participants with PD who have other concurrent movement/neurological conditions, including dystonia, dementia, epilepsy etc.
  6. 6. Participants with a clinical diagnosis of PD that is not considered primary (e.g.
  7. 7. Participants with a history of cancer (whether treated with chemotherapy and/or radiotherapy or not).
  8. 8. Participants with a history of a recent concussion or any facial, neck, or head injury within the last 6 months. UD IRB Approved: 03/12/2025 IRBNet ID#: 2277769-2 I/C from Rev. 01/2024 Page 3 of 10 Participant's Initial's ________
  9. 9. Known injury or disease that might interfere with motor function in the proposed experiments (e.g., stroke, traumatic brain injury, extrapyramidal dysfunction, neuromuscular disease, orthopedic problems that impair movement).
  10. 10. Participants with a history of photosensitivity.
  11. 11. Participants who are not able to walk unassisted for 2 minutes

Contacts and Locations

Study Contact

Sara Penuela, PhD student
CONTACT
9739740120
penuelas@udel.edu
Roxana Burciu, PhD, Associative Professor
CONTACT
rgburciu@udel.edu

Study Locations (Sites)

University of Delaware STAR Tower
Newark, Delaware, 19711
United States

Collaborators and Investigators

Sponsor: University of Delaware

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-04
Study Completion Date2026-07-30

Study Record Updates

Study Start Date2025-04-04
Study Completion Date2026-07-30

Terms related to this study

Additional Relevant MeSH Terms

  • Parkinson Disease